开发和验证一种风险预测模型,用于糖尿病足患者多药耐药生物感染的风险预测模型

Jinghang Zhang1, Xuemei Li1, Bai Chang1

  • 1NHC Key Lab of Hormones and Development and Tianjin Key Lab of Metabolic Diseases, Tianjin Medical University Chu Hsien-I Memorial Hospital & Institute of Endocrinology, Tianjin, China.

Frontiers in endocrinology
|December 29, 2025
PubMed
概括

这项研究开发了名谱模型,以预测糖尿病足 (DFU) 患者的多药耐药生物体 (MDRO) 感染风险. 模型2表现出卓越的性能,有助于早期识别和针对高风险个体的有针对性的干预.